Statins Do Not Decrease the Risk for Wet Age-Related Macular Degeneration

Author： Kaiserman Nadia   Vinker Shlomo   Kaiserman Igor  

Publisher： Informa Healthcare

ISSN： 0271-3683

Source： Current Eye Research, Vol.34, Iss.4, 2009-04, pp. : 304-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response

By  

Ophthalmologica, Vol. 236, Iss. 2, 2016-07 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Visual acuity and its decrease in classic neovascular age-related macular degeneration

By Behrendt Carolyn  

Ophthalmic Epidemiology, Vol. 11, Iss. 5, 2004-12 ,pp. : 359-367

Informa Healthcare

Access to resources Recommend Favorite

Emerging Pharmacologic Therapies for Wet Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 223, Iss. 6, 2009-07 ,pp. : 401-410

Karger

Access to resources Recommend Favorite

Do age-related macular degeneration and cardiovascular disease share common antecedents?

By Snow Kristin K.   Seddon Johanna M.  

Ophthalmic Epidemiology, Vol. 6, Iss. 2, 1999-06 ,pp. : 125-143

Informa Healthcare

Access to resources Recommend Favorite

Micronutrients in Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 229, Iss. 2, 2012-11 ,pp. : 75-79

Karger

Access to resources Recommend Favorite